GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 12, 2025 -- For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a reduced risk for certain complications of DR, according to a study published online Aug. 11 in JAMA Network Open.
David J. Ramsey, M.D., Ph.D., M.P.H., from the UMass Chan-Lahey School of Medicine in Burlington, and colleagues conducted a retrospective cohort study to examine whether use of GLP-1 RAs in patients with T2D is associated with the development of DR, nonarteritic anterior ischemic optic neuropathy (NAION), or DR complications. Adults with T2D and a recent hemoglobin A1c level of 6.5 percent or higher were enrolled and divided into two groups through propensity score matching, based on whether they received prescriptions for a GLP-1 RA.
After propensity score matching, 185,066 individuals were prescribed GLP-1 RAs. The researchers found that GLP-1 RA use was associated with an increased incidence of DR (hazard ratio, 1.07), while no significant increase was seen in the risk for NAION. In a subgroup analysis of 32,695 patients with preexisting DR, there was no association seen for GLP-1 RAs with proliferative DR or diabetic macular edema, but associations were seen with a lower occurrence of vitreous hemorrhages, neovascular glaucoma, or blindness (hazard ratios, 0.74, 0.78, and 0.77, respectively).
"GLP-1 RAs may be a factor in reduced rate of vision loss leading to blindness, even among individuals with preexisting DR," the authors write. "It is crucial that all patients with T2D treated with GLP-1 RAs, regardless of preexisting DR, receive regular screening and monitoring for potential complications of T2D."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Higher Intake of Total Potatoes Linked to Type 2 Diabetes Risk
THURSDAY, Aug. 7, 2025 -- A higher intake of total potatoes, especially French fries, is associated with an increased risk for type 2 diabetes (T2D), according to a study...
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
THURSDAY, Aug. 7, 2025 -- A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many...
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
WEDNESDAY, Aug. 6, 2025 -- Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.